Ovoria
Description
Ovoria, formerly known as First Egg Bank and part of the Medicover Group, claims to be one of the most established egg banks in Europe. Founded in 2001 and headquartered in Lviv, Ukraine, Ovoria has built a global reputation for scientific excellence, strict donor screening, and reliable international logistics. Today, it serves fertility clinics and intended parents across Europe, the UK, and beyond, offering access to a diverse donor pool and one of the most advanced donor egg screening programs in the world. Ovoria’s mission is to make donor egg treatment safe, accessible, and effective, while their vision is to support patients and clinics worldwide with transparent donor profiles, rigorous testing, and efficient shipping solutions. With a strong international orientation, Ovoria ships donor eggs to clinics across Europe, the UK, and worldwide as now deliver oocytes to over 50 clinics in more than 30 countries. Eggs can be delivered within 24–48 hours, ensuring efficiency and minimizing treatment delays. Their multilingual coordination team provides personalized support, assisting patients with donor selection, profile access, and clinic logistics. Services are primarily available in English and Ukrainian, but coordinators are accustomed to supporting patients from diverse cultural and linguistic backgrounds.
Donor types and services
Ovoria provides both anonymous (Non-ID Release) and non-anonymous (ID Release) donation options, depending on the legal framework of the recipient’s country and the donor’s preference. This flexibility allows intended parents to choose between complete anonymity or future disclosure of the donor’s identity, ensuring a more personalized match. The donor catalogue, which includes between 220 and 320 active donors at any given time, features detailed medical and personal information. Profiles provide phenotypic traits, education, personal essays, and in many cases both childhood and adult photographs. All profiles are accessible through Ovoria’s secure online platform, with coordinators available to guide intended parents in the matching process. Donor oocytes are supplied as vitrified eggs in Metaphase II, shipped worldwide using Ovoria’s robust logistics system. Eggs are available in different batch sizes, allowing patients and clinics to select the package that best fits their needs. Standard packages typically include sets of 6, 8, or 12 oocytes, with larger custom batches available upon request. Each package comes with guarantees regarding embryo development or blastocyst formation, providing reassurance and confidence in treatment outcomes. The website does not publish standardized prices, as costs depend on the selected package and the partner clinic through which the treatment is coordinated but it seems to be app. 400 EURO per oocyte delivered in before mentioned packages of 6, 8 and 12.
Genetic test panel
Genetic testing is carried out in two layers: standard screening includes karyotyping, cystic fibrosis, Fragile X, and spinal muscular atrophy (SMA), while extended next-generation sequencing (NGS) panels analyse over 400 genes to detect carriers of autosomal recessive and X-linked disorders. This comprehensive system is designed to minimize genetic risks and ensure the highest safety for recipients and children born from donation.
Origin and locations
Ovoria is headquartered in Lviv, Ukraine, with an international presence through the Medicover fertility network and partner clinics across Europe and the UK.
Additional Information
Owned by Medicover Group.